Pharmacogenomically Selected Treatment for Gastric and Gastroesophageal Junction (GEJ) Tumors

Clinical trial NCT00515216 · COMPLETED

Trial details

NCT number: NCT00515216
Sponsor: Vanderbilt University
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Stomach Neoplasms Esophageal Neoplasms

Start date: 2007-08-01
Primary completion: 2011-08-01
Enrollment: 26

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.